Sveriges Riksbank
Bid procedure, 2021-01-12 | |
Bonds | KOMMUNINVEST I SVERIGE: 2302. SE0009662943. 2023-02-22 KOMMUNINVEST I SVERIGE: 2410, SE0010469205, 2024-10-02 |
Bids | Bids on interest and volume are entered via Bloomberg Bond Auction System |
Bid date | 2021-01-12 |
Bid times | 10.00-11.00 (CET/CEST) on the Bid date |
Requested volume (corresponding nominal amount) | 2302: 1750 mln SEK +/-500 mln SEK 2410: 1750 mln SEK +/-500 mln SEK |
Highest permitted bid volume (corresponding nominal amount) | 2302: 1750 mln SEK per bid 2410: 1750 mln SEK per bid |
Lowest permitted bid volume (corresponding nominal amount) | SEK 50 million per bid |
Expected allocation time | No later than 11.10 (CET/CEST) on the Bid date |
Delivery and payment date | 2021-01-14 |
Delivery of bonds | To the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 |
General Terms and Conditions | General Terms and Conditions General Terms and Conditions for the Riksbank’s Purchases of Bonds via Bid Procedure 2020:3. dated 20 November 2020 (see the Riksbank´s web). |
Stockholm, 2021-01-08
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zealand Pharma18.7.2025 18:30:00 CEST | Press release
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
SpringWorks Therapeutics, Inc.18.7.2025 17:30:40 CEST | Press release
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
Photocat A/S18.7.2025 17:00:00 CEST | Press release
PHOTOCAT has today applied for a transfer of its trading venue from Nasdaq First North Growth Market to Spotlight Stock Market.
Golden Ocean Group Limited18.7.2025 16:30:00 CEST | Press release
GOGL – Notice of Special General Meeting
Kapitalforeningen SDG Invest18.7.2025 16:06:31 CEST | Pressemeddelelse
Kapitalforeningen SDG Invest - Opdateret prospekt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom